Table 3.
Table 3a. Multiple regression for association of Drug Burden Index at baseline (year 1) with functional measures at year 6. | |||||||||
---|---|---|---|---|---|---|---|---|---|
Functional Measure at Year 6 | |||||||||
Short Physical Performance Battery Score | Usual Gait Speed (m/s) | Grip Strength (kg) | |||||||
Factor | B | T | Pr> ItI | B | T | Pr> ItI | B | T | Pr> ItI |
Age | −0.09 | −6.34 | <0.0001 | −0.01 | −6.29 | <0.0001 | −0.25 | −5.89 | <0.0001 |
Sex (Female) | −0.30 | −3.52 | =0.0004 | −0.05 | −5.10 | <0.0001 | −4.20 | −11.39 | <0.0001 |
Race (Black) | −0.31 | −3.38 | =0.0007 | −0.05 | −4.68 | <0.0001 | −0.13 | −0.49 | ns |
Study Site (Memphis) | 0.01 | 0.17 | ns | 0.02 | 1.63 | ns | −0.14 | −0.58 | ns |
Secondary Education (Absent) | −0.11 | −1.01 | ns | −0.03 | −2.62 | =0.009 | 0.75 | 2.43 | <0.05 |
Baseline FCI | −0.10 | −3.55 | =0.0004 | −0.01 | −4.54 | <0.0001 | 0.05 | 0.64 | ns |
Additional comorbidities over 6 years | −0.15 | −2.65 | =0.008 | −0.01 | −2.06 | =0.04 | −0.33 | −1.98 | <0.05 |
Hospitalization years 1-6 | −0.32 | −3.79 | =0.0002 | −0.03 | −3.21 | =0.001 | −0.94 | −3.85 | =0.0001 |
Cumulative Anxiety, Depression, Cognitive Impairment | −0.26 | −4.74 | <0.0001 | −0.02 | −3.79 | =0.0002 | −0.55 | −3.48 | =0.0005 |
Cumulative Sleep Problems | −0.01 | −0.13 | ns | −0.01 | −0.81 | ns | −0.04 | −0.14 | ns |
Baseline Functional Measure | 0.63 | 21.47 | <0.0001 | 0.51 | 22.31 | <0.0001 | 0.64 | 37.48 | <0.0001 |
Baseline Drug Burden Index | −0.29 | −2.67 | =0.008 | −0.04 | −3.26 | =0.001 | −0.56 | −1.76 | =0.08 |
| |||||||||
Adjusted R2 | 0.31 | 0.37 | 0.73 | ||||||
|
Table 3B. Multiple regression for association of the area under the Drug Burden Index - time curve (AUCDB) over five years with functional measures at year 6. | |||||||||
---|---|---|---|---|---|---|---|---|---|
Functional Measure at Year 6 | |||||||||
Short Physical Performance Battery Score | Usual Gait Speed (m/s) | Grip Strength (kg) | |||||||
Factor | B | T | Pr> ItI | B | T | Pr> ItI | B | T | Pr> ItI |
Age | −0.09 | −6.30 | <0.0001 | −0.01 | −6.22 | <0.0001 | −0.25 | −5.91 | <0.0001 |
Sex (Female) | −0.31 | −3.63 | =0.0003 | −0.05 | −5.21 | <0.0001 | −4.26 | −11.53 | <0.0001 |
Race (Black) | −0.31 | −3.40 | =0.0007 | −0.05 | −4.69 | <0.0001 | −0.15 | −0.56 | ns |
Study Site (Memphis) | 0.02 | 0.21 | ns | 0.02 | 1.66 | ns | −0.10 | −0.56 | ns |
Secondary Education (Absent) | −0.11 | −1.05 | ns | −0.03 | −2.64 | =0.008 | 0.73 | 2.38 | =0.02 |
FCI at baseline | −0.10 | −3.54 | =0.0004 | −0.01 | −4.55 | <0.0001 | 0.07 | 0.82 | ns |
Additional comorbidities over 6 years | −0.15 | −2.62 | =0.009 | −0.01 | −2.03 | =0.04 | −0.33 | −1.97 | <0.05 |
Hospitalization years 1-6 | −0.31 | −3.76 | =0.0002 | −0.03 | −3.19 | =0.002 | −0.92 | −3.78 | <0.0005 |
Cumulative Anxiety, Depression, Cognitive Impairment | −0.25 | −4.67 | <0.0001 | −0.02 | −3.73 | =0.0002 | −0.52 | −3.31 | =0.001 |
Cumulative Sleep Problems | −0.01 | −0.10 | ns | −0.01 | −0.79 | ns | −0.01 | −0.04 | ns |
Baseline Functional Measure | 0.63 | 21.69 | <0.0001 | 0.51 | 22.26 | <0.0001 | 0.64 | 37.51 | <0.0001 |
AUCDB | −0.08 | −2.46 | =0.01 | −0.01 | −2.86 | =0.004 | −0.27 | −2.87 | =0.004 |
| |||||||||
Adjusted R2 | 0.30 | 0.37 | 0.73 | ||||||
|